Cantargia AB (publ) (STO:CANTA)
4.500
-0.235 (-4.96%)
At close: Mar 2, 2026
Cantargia AB Employees
Cantargia AB had 22 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
22
Change
n/a
Growth
n/a
Revenue / Employee
14.40M SEK
Profits / Employee
6.68M SEK
Market Cap
1.18B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 22 | 0 | - |
| Sep 30, 2025 | 23 | 2 | 9.52% |
| Jun 30, 2025 | 23 | 0 | - |
| Mar 31, 2025 | 22 | -1 | -4.35% |
| Dec 31, 2024 | 22 | 0 | - |
| Sep 30, 2024 | 21 | -2 | -8.70% |
| Jun 30, 2024 | 23 | 0 | - |
| Mar 31, 2024 | 23 | -1 | -4.17% |
| Dec 31, 2023 | 22 | -4 | -15.38% |
| Sep 30, 2023 | 23 | -4 | -14.81% |
| Jun 30, 2023 | 23 | -4 | -14.81% |
| Mar 31, 2023 | 24 | -4 | -14.29% |
| Dec 31, 2022 | 26 | 0 | - |
| Sep 30, 2022 | 27 | 3 | 12.50% |
| Jun 30, 2022 | 27 | 4 | 17.39% |
| Mar 31, 2022 | 28 | 9 | 47.37% |
| Dec 31, 2021 | 26 | 8 | 44.44% |
| Sep 30, 2021 | 24 | 6 | 33.33% |
| Jun 30, 2021 | 23 | 8 | 53.33% |
| Mar 31, 2021 | 19 | 5 | 35.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BioInvent International AB | 109 |
| Diamyd Medical AB | 41 |
| Egetis Therapeutics AB | 40 |
| Genovis AB (publ.) | 36 |
| Vicore Pharma Holding AB | 36 |
| Saniona AB | 31 |
| Xspray Pharma AB | 26 |
| Medivir AB | 10 |
Cantargia AB News
- 10 days ago - Cantargia AB (FRA:7V3) Q4 2025 Earnings Call Highlights: A Year of First-Time Profitability ... - GuruFocus
- 10 days ago - Q4 2025 Cantargia AB Earnings Call Transcript - GuruFocus
- 3 months ago - Cantargia AB (FRA:7V3) Q3 2025 Earnings Call Highlights: First-Ever Profits and Promising ... - GuruFocus
- 3 months ago - Q3 2025 Cantargia AB Earnings Call Transcript - GuruFocus
- 1 year ago - Cantargia AB (FRA:7V3) Q3 2024 Earnings Call Highlights: Strategic Shifts and Financial Updates - GuruFocus
- 1 year ago - Q3 2024 Cantargia AB Earnings Call Transcript - GuruFocus